SRC and cancer: To further test whether cancer-induced bone pain is associated with an increased phosphorylation of Src and the NR2B during early disease development, western blot analyses were performed on spinal cords from untreated cancer-bearing and sham animals on day 7, 12 and 16 post inoculation.